Quick Comparison
| Bakuchiol | Retinol | |
|---|---|---|
| Typical Concentration | Concentrations: 0.5%-2%. Can be used morning and/or night (not photosensitizing like retinoids). Apply after cleansing. Can be combined with retinoids for enhanced effects. Safe to use without SPF specifically for this ingredient, though daily SPF is always recommended. | Concentrations: 0.025%-1%. Begin with 0.25-0.5% 2-3 times per week. Increase frequency over 4-8 weeks. 1% retinol is roughly equivalent to 0.025% tretinoin in efficacy. Apply at night after cleansing. Encapsulated/stabilized forms (retinol in liposomes) are less irritating. |
| Application | Topical (serum, oil, cream). Stable in formulation. Not photosensitizing. | Topical (serum, cream, oil). Apply at night. Look for products in opaque, airless pump packaging — retinol degrades rapidly with air and light exposure. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
Bakuchiol
Bakuchiol (meroterpene from Psoralea corylifolia) achieves retinol-like effects through RAR/RXR-independent pathways. It upregulates collagen I and III in fibroblasts via TGF-beta/Smad signaling and possibly ER-beta cross-talk. Bakuchiol downregulates MMP-1, preserving dermal collagen. It accelerates keratinocyte differentiation and stratum corneum turnover through distinct pathways. Direct antioxidant activity scavenges ROS and inhibits lipid peroxidation. Anti-inflammatory effects may involve NF-kappaB modulation. Clinical studies show comparable wrinkle reduction to 0.5% retinol; combination with retinol shows synergy. Safe during pregnancy—does not activate retinoic acid receptors.
Retinol
Retinol undergoes two-step enzymatic conversion in keratinocytes: alcohol dehydrogenase (ADH) and retinol dehydrogenase (RDH) oxidize retinol to retinaldehyde; retinaldehyde dehydrogenase (RALDH) then oxidizes it to all-trans retinoic acid. Conversion is rate-limited by enzyme availability and CRBP expression, delivering retinoic acid gradually—explaining retinol's gentler profile. Only retinoic acid binds RAR/RXR receptors. Once converted, it activates identical pathways as tretinoin: upregulating keratinocyte proliferation, stimulating fibroblast collagen I/III via TGF-beta, inhibiting MMPs, and normalizing melanocyte activity. Multi-step metabolism creates tissue-specific conversion favoring epidermal effects. Identical downstream effects to tretinoin with reduced irritation.
Risks & Safety
Bakuchiol
Common
Very few — bakuchiol is exceptionally well-tolerated. Mild tingling in some users initially.
Serious
None documented. Safe during pregnancy.
Rare
Allergic reaction (rare plant allergy).
Retinol
Common
Dryness, flaking, mild redness, sun sensitivity (use SPF daily). Less severe than tretinoin.
Serious
Avoid during pregnancy (precautionary — less evidence than tretinoin but same class).
Rare
Contact dermatitis in sensitive individuals.
Full Profiles
Bakuchiol →
A plant-derived compound from Psoralea corylifolia seeds that provides retinol-like benefits without retinoid chemistry. Bakuchiol does not bind to retinoic acid receptors — it achieves similar gene expression changes through a completely different mechanism, making it safe during pregnancy and for skin too sensitive for any retinoid. Clinical studies show comparable improvements in wrinkles and pigmentation to 0.5% retinol.
Retinol →
The most popular over-the-counter retinoid. Retinol must be converted by skin enzymes into retinaldehyde, then into retinoic acid (tretinoin) to become active. This multi-step conversion means retinol is roughly 10-20x less potent than prescription tretinoin, but also significantly less irritating — making it the entry point for retinoid beginners.